J.P. Morgan Notebook, Jan. 13: Regeneron, AstraZeneca, CRISPR And Juno
This article was originally published in The Pink Sheet Daily
Executive Summary
Daily round-up of news and notes from the 2016 J.P. Morgan Healthcare Conference in San Francisco.